Purchase Order 75N92025P00009
Award Date
12/8/24
Potential Completion Date
12/7/25
Potential Value
$15K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $95,931.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is for the purchase of an Illumina MiSeq2 sequencing system and associated components. Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, is the prime contractor. This contract does not have a set-aside designation. Illumina has provided...
This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the acquisition of an Illumina MiSeq System. The contract has a ceiling value of $95,931.00 and a completion date of August 31, 2019. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has received past prime contract awards from various federal agencies to support their...
This is a firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq support plan. The contract has a ceiling value of $85,029.08 and a period of performance through September 11, 2029. Illumina, a manufacturer of genetic sequencing instruments and reagents, has provided a range of sequencing products and services to support research and diagnostics across various...
This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
This is a $15,849.80 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the maintenance of a MiSeq M06580 DNA sequencing instrument and associated services. The contract has a period of performance through September 11, 2026. Illumina, a manufacturer of genomic sequencing technologies, has been awarded multiple federal contracts and grants by the NIH, Centers...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
This $28,709.96 firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the maintenance and support of a NextSeq sequencing instrument to enable DNA sequencing and genomics research for NHLBI principal investigators, fellows, and staff. The award has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $19,250.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics and sequencing products. The contract is for a MiSeq system health check to be provided on a quarterly basis. Illumina has a history of providing sequencing instruments, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA to support genomics...
This firm fixed-price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $84,341 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis for research and diagnostic...